Predict clinical seizure liability with 83% sensitivity and 89% specificity using CNS-3D Brain Organoids. Watch the Endurance Study webinar on-demand.

Explore CNS-3D and PNS-3D human organoids for modeling myelin disruption, repair, and therapeutic assessment.

Explore how Organoid Intelligence offers a new way to measure memory and learning, advancing functional biomarkers for Alzheimer’s and dementia drug development.

CNS-3D brain organoids offer reliable CNS Safety assessments.